Search
Returning search results with filters:
Remove filter for
Issue: New safety information
Remove filter for
Last updated: 2022
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
- (-) 2022
- December 20221 results available
- October 20222 results available
- September 20222 results available
- August 20221 results available
- July 20221 results available
- May 20221 results available
- April 20222 results available
- March 20221 results available
- February 20222 results available
- January 20223 results available
Displaying 1 - 15 of 16 items.
OCALIVA (obeticholic acid) – New Contraindication for the Treatment of Primary Biliary Cholangitis (PBC)
AlertHealth professional risk communication | 2022-12-05
Janus Kinase Inhibitors and the Risk of Major Adverse Cardiovascular Events, Thrombosis (Including Fatal Events) and Malignancy
AlertHealth professional risk communication | 2022-10-31
EVUSHELD (tixagevimab and cilgavimab for injection) - Risk of Prophylaxis or Treatment Failure due to Antiviral Resistance
AlertHealth professional risk communication | 2022-10-26
Magnets in certain Philips Respironics sleep therapy masks may cause serious injury to some individuals
AlertPublic advisory | 2022-09-26
ZOLGENSMA (onasemnogene abeparvovec) and Fatal Cases of Acute Liver Failure
AlertHealth professional risk communication | 2022-09-12
IMBRUVICA (ibrutinib) - Risk of Serious and Fatal Cardiac Arrhythmias or Cardiac Failure
AlertHealth professional risk communication | 2022-08-29
IMVAMUNE Vaccine: Updated Storage Conditions and Shelf Life
AlertHealth professional risk communication | 2022-07-29
COMIRNATY (COVID-19 Vaccine, mRNA, also referred to as Pfizer-BioNTech COVID-19 Vaccine): New Formulation/Presentation for Use in Individuals 12 Years of Age and Older
AlertHealth professional risk communication | 2022-05-09
Sotrovimab for Injection - Risk of Treatment Failure due to Circulation of SARS-CoV-2 Omicron BA.2 Subvariant
AlertHealth professional risk communication | 2022-04-14
Anticipated shortage of euthanasia products for animals
AlertHealth professional risk communication | 2022-03-10
Rapid antigen test kits and potential exposure to hazardous substances
AlertPublic advisory | 2022-02-24
BEOVU (brolucizumab) – Risk of Intraocular Inflammation, Retinal Vasculitis and/or Retinal Vascular Occlusion
AlertHealth professional risk communication | 2022-02-03
PAXLOVID (nirmatrelvir and ritonavir) - Dosing and Dispensing in Renal Impairment, Risk of Serious Adverse Reactions Due to Drug Interactions, and English-Only Labels
AlertHealth professional risk communication | 2022-01-17
XELJANZ/XELJANZ XR (tofacitinib) – Risk of Major Adverse Cardiovascular Events, Malignancy, Thrombosis and Infection
AlertHealth professional risk communication | 2022-01-12